JAK2 and hepatocellular carcinoma: Besides, we identified that a clinical anti‐inflammatory drug alminoprofen targeted C21orf58, displayed an attractive anti‐tumor efficacy on HCC treatment by preventing the formation of JAK2/C21orf58/STAT3 complex, resulting in suppression of STAT3 cascades (Figure 8).